Regulatory considerations for development of bioanalytical assays for biotechnology products.

Regulatory considerations for development of bioanalytical assays for biotechnology products.

Item
http://www.wikidata.org/entity/Q54382464
Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis.Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.Evaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology PerspectiveStrategic selection and development of immunogenicity binding methods.When assay format matters: a case study on the evaluation of three assay formats to support a clinical pharmacokinetic study.Carbon paste electrode modified with cuo-nanoparticles as a probe for square wave voltammetric determination of atrazine.A generic template for automated bioanalytical ligand-binding assays using modular robotic scripts in support of discovery biotherapeutic programs.
P2860

Regulatory considerations for development of bioanalytical assays for biotechnology products.

Item
http://www.wikidata.org/entity/Q54382464
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Regulatory considerations for ...... ys for biotechnology products.
@en
Regulatory considerations for ...... ys for biotechnology products.
@nl
type
label
Regulatory considerations for ...... ys for biotechnology products.
@en
Regulatory considerations for ...... ys for biotechnology products.
@nl
prefLabel
Regulatory considerations for ...... ys for biotechnology products.
@en
Regulatory considerations for ...... ys for biotechnology products.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Regulatory considerations for ...... ys for biotechnology products.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921